HYDE-SMITH SAYS FDA SHOULD FOLLOW LAW TO EXPEDITE APPROVAL OF LOWER-COST INSULIN PRODUCTS
HYDE-SMITH SAYS FDA SHOULD FOLLOW LAW TO EXPEDITE APPROVAL OF LOWER-COST INSULIN PRODUCTS
Miss. Senator Successfully Advocated for Inclusion of Insulin Affordability Provisions in FY2020 Appropriations Measure
WASHINGTON, D.C. – U.S. Senator Cindy Hyde-Smith (R-Miss.) today said the Food and Drug Administration (FDA) must act expeditiously to implement legislation she cosponsored to help reduce prices by accelerating the approval of lower-cost, generic insulin products.
Hyde-Smith cosponsored...